These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 7940937)
1. Pharmacokinetics of a new galenical formulation of oral cyclosporine A in stable kidney transplanted patients. Foradori AC; Martínez L; Vacarezza A; Elberg L; Loveluck A; Pinto C Transplant Proc; 1994 Oct; 26(5):2969-72. PubMed ID: 7940937 [No Abstract] [Full Text] [Related]
2. Comparison of the pharmacokinetics of cyclosporine Sandimmune with Sandimmune Neoral in stable renal transplant patients. Sketris IS; Lawen JG; Beauregard-Zollinger L; Belitsky P; Landsberg D; Givner ML; Keown P Transplant Proc; 1994 Oct; 26(5):2961-3. PubMed ID: 7940935 [No Abstract] [Full Text] [Related]
3. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients. Schiavelli R; Sgrosso JL; Sabbatiello R; Castro C; Ahualli L; Pattin M; Vazquez MC Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299 [No Abstract] [Full Text] [Related]
4. Preliminary pharmacokinetic evaluation of a new galenical formulation of oral cyclosporine A: Neoral TM. Foradori AC; Martínez L; Elberg A; Vaccarezza A; Loveluck A; Pinto C Transplant Proc; 1995 Apr; 27(2):1813-4. PubMed ID: 7725515 [No Abstract] [Full Text] [Related]
5. Sandimmun neoral pharmacokinetics: impact of the new oral formulation. Holt DW; Mueller EA; Kovarik JM; van Bree JB; Richard F; Kutz K Transplant Proc; 1995 Feb; 27(1):1434-7. PubMed ID: 7878935 [No Abstract] [Full Text] [Related]
6. Evaluation of the new cyclosporine formulation, Consupren, in renal transplant patients. Stephan AG; Barbari A; Masri MA; Rizk S; Moubarak R; Frem GJ; Kamel G; Baracat-Khoury W; Karam A Transplant Proc; 1996 Jun; 28(3):1348-9. PubMed ID: 8658688 [No Abstract] [Full Text] [Related]
7. Sandimmun neoral, a new oral formulation of cyclosporin A with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients. Taesch S; Niese D; Mueller EA Transplant Proc; 1994 Dec; 26(6):3147-9. PubMed ID: 7998097 [No Abstract] [Full Text] [Related]
8. Cyclosporine pharmacokinetics in stable renal transplant patients: effect of formulation Sandimmun versus Consupren versus Neoral. Masri MA; Barbari A; Stephan A; Kamel G; Frem G; Younan F; Rizk S; Moubarak R; Karam A Transplant Proc; 1996 Jun; 28(3):1318-20. PubMed ID: 8658676 [No Abstract] [Full Text] [Related]
9. Pharmacokinetic profile of cyclosporine in long-term heart transplanted patients treated with a new oral formulation. Fiocchi R; Mamprin F; Gamba A; Glauber M; Catania S; Cattaneo G; Torre L; Bertocchi C; Ruhrmann R; Colombo D Transplant Proc; 1994 Oct; 26(5):2994-5. PubMed ID: 7940945 [No Abstract] [Full Text] [Related]
10. Assessment of glomerular filtration rate after multiple administration of a new oral formulation of cyclosporine in clinically stable renal transplant patients. Mueller EA; Kallay Z; Kovarik JM; Arns W; Renner E; Kutz K Transplant Proc; 1995 Feb; 27(1):834-6. PubMed ID: 7879198 [No Abstract] [Full Text] [Related]
11. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral. Vathsala A; Lee WT; Jacob E; Woo KT Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678 [No Abstract] [Full Text] [Related]
12. Cyclosporine levels in diabetic (type 1) patients undergoing kidney and pancreas transplantation: role of a new galenica formulation. Storck M; Mickley V; Gräb C; Steinbach G; Abendroth D Transplant Proc; 1994 Oct; 26(5):2996-8. PubMed ID: 7940946 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics of oral cyclosporine A in stable kidney transplant recipients: a critical review. Foradori AC; Martínez L; Elberg A; Vacarezza A; Loveluck A; Pinto C Transplant Proc; 1995 Apr; 27(2):1815-6. PubMed ID: 7725516 [No Abstract] [Full Text] [Related]
14. Long-term results of conversion from existing to microemulsion formulation of cyclosporine. Neumayer HH; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC Transplant Proc; 1996 Aug; 28(4):2207-13. PubMed ID: 8769202 [No Abstract] [Full Text] [Related]
15. Case study: de novo application of Neoral in renal transplantation. Kahan BD Transplant Proc; 1996 Aug; 28(4):2189-91; discussion 2192, 2195. PubMed ID: 8769196 [No Abstract] [Full Text] [Related]
16. Effect of dietary fat on the pharmacokinetics and pharmacodynamics of cyclosporine in renal transplant recipients. Tan KK; Trull AK; Uttridge JA; Metcalfe S; Heyes CS; Facey S; Evans D Transplant Proc; 1994 Oct; 26(5):2955-6. PubMed ID: 7940932 [No Abstract] [Full Text] [Related]
17. A study to assess the efficacy, tolerability, and safety of a new oral formulation of Sandimmun--Sandimmun Neoral--in stable renal transplant patients. Rosental R; Bicans J; Berzina R; Zezina L Transplant Proc; 1995 Dec; 27(6):3436-7. PubMed ID: 8540038 [No Abstract] [Full Text] [Related]
18. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation. Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219 [No Abstract] [Full Text] [Related]
19. Pharmacokinetics of oral cyclosporine in children awaiting renal transplantation. Gusmano R; Verrina E; Piaggio G; Corbetta G; Basile GC; Perfumo F Transplant Proc; 1994 Oct; 26(5):2781-3. PubMed ID: 7940877 [No Abstract] [Full Text] [Related]
20. New cyclosporine microemulsion randomized, cross-over bioequivalence steady-state study in renal transplanted patients. Sinescu I; Lopes HV; Foschi D; Jen LH; Oliani C Eur Rev Med Pharmacol Sci; 1999; 3(1):11-8. PubMed ID: 10710824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]